• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number UNK717
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Congestive Heart Failure (1783); Death (1802); Edema (1820); Weakness (2145)
Event Date 09/21/2015
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2016-01494.(b)(4) clinical study it was reported that the patient died.In (b)(6) 2013, the patient presented due to silent ischemia and coronary angiography was performed.Target lesion #1 was located in the distal left circumflex (lcx) artery with 100% stenosis and was 30.00mm long with a reference vessel diameter of 3.00mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00x32.00mm promus element plus drug-eluting stent.Following post-dilatation, residual stenosis was 0%.Target lesion #2 was located in the proximal lcx with 80% stenosis and was 20.00mm long with a reference vessel diameter of 3.50mm.Target lesion #2 was treated with pre-dilatation and placement of a 3.00x20.00mm promus element plus drug-eluting stent.Following post-dilatation, residual stenosis was 10%.On the same day, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient was admitted due to hyponatremia and despite multiple attempts with medications, the patient's sodium did not correct.Twelve days after, the patient was discharged.Since the discharge, the patient was having weakness, increased weight gain and leg swelling.In (b)(6) 2015, the patient was admitted to the emergency department due to increased weakness, acute on chronic systolic congestive heart failure (chf) and worsening renal failure.The patient was hypotensive and the worsening kidney function was in setting of fluid overload and more chf.The patient had no urine output since over 24 hours prior to admission.The patient was also noted to have severe renal artery stenosis (ras) which would make the patient more sensitive to fluid shifts.The patient was started on dobutamine drip to aid diuresis and was admitted to the intensive care unit (icu).The patient's oxygen requirement increased and thus the patient was placed on continuous positive airway pressure (cpap).Despite these attempts, the patient's blood pressure did not improve and oxygen saturation dropped.The patient was getting more obtunded and after consultation with cardiologist, renal intensivist and discussion with family members, comfort care measures were placed.The following day, the patient expired.The preliminary cause of death was end stage heart failure with organ failures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5503136
MDR Text Key40386302
Report Number2134265-2016-01493
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 02/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK717
Device Lot NumberBATCH_UNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age68 YR
-
-